P-574. Characterization of N. meningitidis in Military Trainees and Implications for Vaccination Strategies

Abstract Background N. meningitidis is a gram-negative pathogen that is part of normal oropharyngeal flora, but can also cause meningitis outbreaks in susceptible populations, especially when encapsulated. The United States military vaccinates all entering trainees with a quadrivalent vaccine against serogroups A, C, W, and Y, but does not currently vaccinate against serogroup B. This study identified the predominant meningococcal serogroups (A, B, C, W, X, Y) in trainees upon arrival to BMT. Methods Between June-August 2024, a convenience sample of 909 trainees received oropharyngeal swabs before meningococcal vaccination or penicillin prophylaxis. Swabs were cultured and subsequently serogrouped by polymerase chain reaction (PCR) as well as whole genome sequencing. For those that were PCR positive for serogroup B, the Meningococcal Antigen Typing System was used to determine coverage by the MenB-4C vaccines. Results Of the 909 samples collected, 35 (3.9%) trainees were found to have oropharyngeal carriage of N. meningitidis and 4 (0.4%) were found to have oral infection with N. gonorrhoeae. Of the N. meningitidis isolated, 11 (31%) were able to be classified by serogroup by PCR with serogroup B accounting for the majority (72.7%) of groupable isolates. By whole genome sequencing, all N. meningitidis strains were found to be non-groupable, except for one isolate in serogroup C. The FDA approved serogroup B vaccine targets sub-capsular proteins, and not the capsule itself. Sequencing predicts that six (75%) of the serogroup B PCR positive samples would be targeted by the MenB-4C vaccine, with one being unpredictable, and one not covered. Conclusion The vast majority of oropharyngeal isolates of N. meningitidis in a convenience sample of military trainees were non-groupable by whole genome sequencing despite having components of the capsule genes that are detectable by PCR. This data supports current practices of not vaccinating military trainees for serogroup B meningococcus. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.789
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-574. Characterization of N. meningitidis in Military Trainees and Implications for Vaccination Strategies

Joseph C. Marcus, Ga On Jung, Angela Osuna, John L Kiley et al.
Open Forum Infectious Diseases
Bacterial Infections and Vaccines
article

P-574. Characterization of N. meningitidis in Military Trainees and Implications for Vaccination Strategies

Joseph C. Marcus, Ga On Jung, Angela Osuna, John L Kiley, Thomas F. Gibbons, Brian Casleton, Theresa Casey, Hui Xia, Kevin M Kashuba-Shanahan, Erin Winkler, Lori Henrichs
article en

Abstract

Abstract Background N. meningitidis is a gram-negative pathogen that is part of normal oropharyngeal flora, but can also cause meningitis outbreaks in susceptible populations, especially when encapsulated. The United States military vaccinates all entering trainees with a quadrivalent vaccine against serogroups A, C, W, and Y, but does not currently vaccinate against serogroup B. This study identified the predominant meningococcal serogroups (A, B, C, W, X, Y) in trainees upon arrival to BMT. Methods Between June-August 2024, a convenience sample of 909 trainees received oropharyngeal swabs before meningococcal vaccination or penicillin prophylaxis. Swabs were cultured and subsequently serogrouped by polymerase chain reaction (PCR) as well as whole genome sequencing. For those that were PCR positive for serogroup B, the Meningococcal Antigen Typing System was used to determine coverage by the MenB-4C vaccines. Results Of the 909 samples collected, 35 (3.9%) trainees were found to have oropharyngeal carriage of N. meningitidis and 4 (0.4%) were found to have oral infection with N. gonorrhoeae. Of the N. meningitidis isolated, 11 (31%) were able to be classified by serogroup by PCR with serogroup B accounting for the majority (72.7%) of groupable isolates. By whole genome sequencing, all N. meningitidis strains were found to be non-groupable, except for one isolate in serogroup C. The FDA approved serogroup B vaccine targets sub-capsular proteins, and not the capsule itself. Sequencing predicts that six (75%) of the serogroup B PCR positive samples would be targeted by the MenB-4C vaccine, with one being unpredictable, and one not covered. Conclusion The vast majority of oropharyngeal isolates of N. meningitidis in a convenience sample of military trainees were non-groupable by whole genome sequencing despite having components of the capsule genes that are detectable by PCR. This data supports current practices of not vaccinating military trainees for serogroup B meningococcus. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Brooke Army Medical Center (US), Wilford Hall Ambulatory Surgical Center (US), Defense Health Agency (US), Kozlovsky Delay & Winter Eye Consultants (US), San Antonio Uniformed Services Health Education Consortium (US), Joint Base San Antonio (US)
Good health and well-being
Openalex Percentile: Top 92%
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.